LCIF and the Carter Center Recognized for their Work Battling Trachoma
*Photo courtesy of the Carter Center
Did you know that Lions Clubs International Foundation (LCIF) has demonstrated a commitment to not only controlling but eliminating certain neglected tropical diseases that threaten vision for the some of the world’s most vulnerable populations?
Commonly known as NTDs, the term “neglected tropical diseases” refers to a particular group of communicable diseases that prevail in tropical and subtropical conditions in 149 countries. Both onchocerciasis (river blindness) and trachoma are considered NTDs and both are leading causes of blindness in particular areas of the world.
LCIF’s SightFirst program funds the efforts of Lions, nongovernmental organizations, government agencies and others to fight the major causes of preventable and reversible blindness, and provide services to persons who are blind or have a visual impairment. Trachoma will continue to remain a priority for SightFirst; click here to learn more about what that means.
The Chronicle of Philanthropy recently published an article highlighting the massive drug donation to NTDs, with a focus on trachoma. In addition to recognizing the Carter Center, Pfizer and the other pharmaceutical donors, the article also recognizes the critical contributions of partner organizations, like LCIF, that support the distribution of the donated medicines in the context of broader disease elimination strategies.
Check out this @Philanthropy article highlighting @hiltonfound, @lionsclubs, @KellyCTrachoma, and 20 years of impact against trachoma with @pfizer @ITIatlanta donated drug! #endtrachoma https://t.co/7UcODHsuh7
— The Carter Center (@CarterCenter) September 11, 2018